Skip to main content
SpringerLink
Log in

Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

The lipid metabolomic profile has been well defined in the pathogenesis and differential diagnosis in patients with different myeloid diseases. We assumed that the serum lipid metabolites could also help the diagnosis and prognostic prediction of aplastic anemia (AA). In this study, serum lipid profiles were explored in AA patients before and after cyclosporin (CsA) treatment. Meanwhile, hypocellular myelodysplastic syndrome (h-MDS) patients and the healthy volunteers were compared as controls. 15 AA patients, 11 h-MDS patients and 20 age and sex matched health controls were enrolled. All the AA patients were diagnosed to be non-severe aplastic anemia with transfusion dependency and were treated by CsA 3–5 mg/kg/d for at least 6 months. AA patients had decreased arachidonic acid pathway metabolites and retinol metabolism-related metabolites as compared with h-MDS and the health (P < 0.05), whereas h-MDS patients had increased metabolism of proline and threonine and abnormal sphingolipid metabolism compared with AA patients and the normal controls. After 6 month of CsA treatment, serum arachidonic acid, PGE2, PGJ2, 15(S)-HETE, leukotriene B4 and Protectin D1 decreased significantly. Patients who had response to CsA had higher levels of baseline protectin D1 (P = 0.011), leukotriene B4 (P = 0.011), 15(S)-HETE (P = 0.004) and all-trans-retinal (P = 0.000) than those who had no response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Afable MG, Tiu RV, Maciejewski JP. Clonal evolution in aplastic anemia. Hematol, Am Soc Hematol Educ Progr Book. 2010;2011:90–5.

    Article  Google Scholar 

  2. Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020;136(1):36–49.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Oliveira AR, Silva I, LoTurco E, Martins H, Chauffaille ML. Initial analysis of lipid metabolomic profile reveals differential expression features in myeloid malignancies. Blood. 2014;124(21):5958.

    Article  Google Scholar 

  4. Khalid A, Siddiqui AJ, Huang JH, Shamsi T, Musharraf SG. Alteration of serum free fatty acids are indicators for progression of pre-leukaemia diseases to leukaemia. Sci Rep. 2018;8(1):14883.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Musharraf SG, Siddiqui AJ, Shamsi T, Naz A. SERUM metabolomics of acute lymphoblastic leukaemia and acute myeloid leukaemia for probing biomarker molecules. Hematol Oncol. 2017;35(4):769–77.

    Article  CAS  PubMed  Google Scholar 

  6. Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood. 1975;45(3):355–63.

    Article  CAS  PubMed  Google Scholar 

  7. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43–70.

    Article  CAS  PubMed  Google Scholar 

  8. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.

    Article  CAS  PubMed  Google Scholar 

  9. Gottfried EL. Lipids of human leukocytes: relation to celltype. J Lipid Res. 1967;8(4):321–7.

    Article  CAS  PubMed  Google Scholar 

  10. Ahamed M, Kumar A, Siddiqui MK. Lipid peroxidation and antioxidant status in the blood of children with aplastic anemia. Clin Chim Acta; Int J Clin Chem. 2006;374(1–2):176–7.

    Article  CAS  Google Scholar 

  11. Sultanova UA, Karimov KHIA, Khuzhakhmedov ZHD. Lipid peroxidation and activity of antioxidative protection enzymes in patients with aplastic anemia. Likars’Ka Sprava. 2009;3–4(3–4):27–31.

    Google Scholar 

  12. Ravera S, Degan P, Sabatini F, Columbaro M, Dufour C, Cappelli E. Altered lipid metabolism could drive the bone marrow failure in Fanconi anaemia. Br J Haematol. 2019;184(4):693–6.

    Article  PubMed  Google Scholar 

  13. Rizzo MT. The role of arachidonic acid in normal and malignant hematopoiesis. Prostaglandin Leukot Essent Fatty Acids (PLEFA). 2002;66(1):57–69.

    Article  CAS  Google Scholar 

  14. Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyoğlu D. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clinical. 2017;7:105–14.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rossi GB, Migliaccio AR, Migliaccio G, et al. In vitro interactions of PGE and cAMP with murine and human erythroid precursors. Blood. 1980;56(1):74–9.

    Article  CAS  PubMed  Google Scholar 

  16. Desplat V, Ivanovic Z, Dupuis F, Faucher JL, Denizot Y, Praloran V. Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. Blood Cells Mol Dis. 2000;26(5):427–36.

    Article  CAS  PubMed  Google Scholar 

  17. Stenke L, Mansour M, Reizenstein P, Lindgren JA. Stimulation of human myelopoiesis by leukotrienes B4 and C4: interactions with granulocyte-macrophage colony-stimulating factor. Blood. 1993;81(2):352–6.

    Article  CAS  PubMed  Google Scholar 

  18. Phang JM. Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses. Antioxid Redox Signal. 2019;30(4):635–49.

    Article  CAS  PubMed  Google Scholar 

  19. Elia I, Broekaert D, Christen S, et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun. 2017;8:15267.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chen G, Wang J. Threonine metabolism and embryonic stem cell self-renewal. Curr Opin Clin Nutr Metab Care. 2014;17(1):80–5.

    CAS  PubMed  Google Scholar 

  21. Barth BM, Wang W, Toran PT, et al. Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia. Blood Adv. 2019;3(17):2598–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Seumois G, Fillet M, Gillet L, et al. De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis. J Leukoc Biol. 2007;81(6):1477–86.

    Article  CAS  PubMed  Google Scholar 

  23. Limbkar K, Dhenge A, Jadhav DD, Thulasiram HV, Kale V, Limaye L. Data on the effect of oral feeding of arachidonic acid or docosahexanoic acid on haematopoiesis in mice. Data Brief. 2017;14:551–7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 1980;77(5):2936–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia. 2002;16(10):1896–905.

    Article  CAS  PubMed  Google Scholar 

  26. Cañete A, Cano E, Muñoz-Chápuli R, Carmona R. Role of vitamin A/retinoic acid in aregulation of embryonic and adult hematopoiesis. Nutrients. 2017;9(2):159.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Collins SJ. Retinoic acid receptors, hematopoiesis and leukemogenesis. Curr Opin Hematol. 2008;15(4):346–51.

    Article  CAS  PubMed  Google Scholar 

  28. Tang D, Liu S, Sun H, et al. All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia. Br J Haematol. 2020;191(5):906–19.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by grants from Beijing Natural Science Foundation (7192168), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019XK 320047), CAMS Innovation Fund for Medical Sciences (2021-I2M-1-003), the National Key Research and Development Program of China (2016YFC0901500) and National Natural Science Foundation of China (81970106).

Author information

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, 100730, China

    Jing Ruan, Chen Yang, Yali Du, Miao Chen & Bing Han

Authors
  1. Jing Ruan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yali Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bing Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. MC, YD and CY helped to collect clinical data and provide critical suggestions. Material preparation and data analysis were performed by JR and BH The first draft of the manuscript was written by JR, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Bing Han.

Ethics declarations

Conflict of interest

We declare no conflict of competing interests.

Ethical approval

The study protocol was approved by the Ethics Committee of Peking Union Medical College Hospital.

Informed consent

Informed consent was obtained from all the patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruan, J., Yang, C., Du, Y. et al. Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia. Clin Exp Med 23, 767–776 (2023). https://doi.org/10.1007/s10238-022-00826-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-022-00826-z

Keywords

Search

Navigation